FDA Inspection 1122354 — Biomat USA, Inc
The FDA completed an inspection of Biomat USA, Inc on March 6, 2020 in Bellflower, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 6, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Bellflower, CA (United States)